Small Cap Stocks Down Under 26 August 2022: Pacific Smiles (ASX:PSQ)

Pacific Smiles: Still facing disruption, but set for a strong FY23

Pacific Smiles (ASX: PSQ) has been significantly disrupted by COVID-19, but the guidance it gave for FY23 suggests it thinks the worst is over. The dental franchise is expecting patient fees of $270-$285m and EBITDA of $24-$27m, which would be up 23% and 126% on FY22 respectively. If it can achieve these figures, there could be significant upside in the stock. But the bar has been set quite high.

Click here to read the previous edition of Small Cap Stocks Down Under published 19 August 2022.

For in-depth research reports on ASX-listed stocks, check out our parent company, Pitt Street Research, or follow us on Facebook and Twitter.